Results 11 to 20 of about 172,155 (289)
t(5;12)(p13;p13) NIPBL/ETV6 [PDF]
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2013 Review on t(5;12)(p13;p13) NIPBL/ETV6, with data on clinics, and the genes involved.
De, Braekeleer E +6 more
openaire +2 more sources
Detection of t(7;12)(q36;p13) in paediatric leukaemia using dual colour fluorescence in situ hybridisation [PDF]
, 2015 The identification of chromosomal rearrangements is of utmost importance for the diagnosis and classification of specific leukaemia subtypes and therefore has an impact on therapy choices in individual cases.
Federico, C +4 more
core +2 more sources
Clinical Case Reports, 2022 The COVID‐19 pandemic highlighted the benefits of subcutaneous (SC) administration for healthcare systems. The first SC infliximab, CT‐P13 SC, was safe and effective for the treatment of psoriatic arthritis. Observed patient preferences for continuing CT‐
Xenofon Baraliakos +4 more
doaj +1 more source
Ultra Luminous X-ray sources - new distance indicators? [PDF]
, 2018 In this paper we fit the NuSTAR and XMM-Newton data of three sources: NGC7793~P13, NGC5907~ULX1, and Circinus~ULX5. Our single model contains emission form non-spherical system: neutron star plus accretion disk directed towards observer.
Adhikari, Tek P. +4 more
core +2 more sources
Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2011 Review on t(12;17)(p13;p13), with data on clinics, and the genes involved.
openaire +2 more sources
Frontiers in Neurology, 2022 ObjectiveWe compared the characteristics of air-conducted sound cervical vestibular evoked myogenic potential (ACS-cVEMP) and bone-conducted vibration cVEMP (BCV-cVEMP) among 3-month-old infants with normal hearing and sensorineural hearing loss (SNHL ...
Jiali Shen +43 more
doaj +1 more source
مجلة كلية الطب, 2023 Background: Ankylosing spondylitis is a rare disease affecting people with hereditary factors. Its treatment includes life style modification and use of drugs such as the biologic agent infliximab or its biosimilar, CT-P13 infliximab.
Mohammed M. Kamil +2 more
doaj +1 more source
Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13) [PDF]
, 2002 The ETV6 gene (first identified as TEL) is a frequent target of chromosomal translocations in both myeloid and lymphoid leukemias. At present, more than 40 distinct translocations have been cytogenetically described, of which 13 have now also been ...
Cools, J. (J.) +7 more
core +1 more source
Gut and Liver, 2023 Background/Aims: The clinical efficacy and safety of CT-P13 are comparable to originator infliximab for Crohn’s disease in CT-P13 3.4 study (NCT02096861).
Jihye Park +9 more
doaj +1 more source
mAbs, 2021 The biosimilar concept is now well established. Clinical data accumulated pre- and post-approval have supported biosimilar uptake, in turn stimulating competition in the biologics market and increasing patient access to biologics. Following technological
HoUng Kim +16 more
doaj +1 more source